Teva Pharmaceutical announced a proposal to acquire all of the outstanding shares of Mylan in a transaction valued at $40 billion Read the full story

Teva and Auspex Pharmaceuticals have entered into a definitive merger agreement Read the full story

Teva Pharmaceutical Industries has entered into a $120 million pharma licensing agreement that will allow it to distribute and promote a competitor to its own cancer drug, Eagle Pharmaceuticals EP-3102. Read the full story

Teva Pharmaceutical Industries announced that Teva has entered into a definitive m&a agreement to acquire Labrys, broadening Teva’s array of biotechnology assets and capabilities. Read the full story

The term 'top pharma' can relate to the top pharmaceutical companies or the top 10 or 50... Read the full story

Teva Pharmaceuticals is a top pharmaceutical company based in Petach Tikva, Israel Read the full story

Teva Pharmaceuticals USA and Volunteers in Medicine announced their 2014 pharma alliance to make healthcare services more readily available to the uninsured. Read the full story

MDxHealth has signed an exclusive pharma licensing agreement with Teva Pharmaceuticals for commercialization of ConfirmMDx for Prostate Cancer and PredictMDx for Glioblastoma tests in Israel. Read the full story

Latest M&A news is that Nupathe rejects the acquisiton offer by  Endo Health soultion and has agreed to be acquired by Teva Pharmaceuticals for $144 million in cash. Read the full story

Teva entered pharma licensing with Takeda  to commercialize Teva’s innovative glatiramer acetate formulation for the treatment of multiple sclerosis, in Japan. Read the full story